Unlimited Bio Registers First-in-Class Dual Gene Therapy Trial
SINGAPORE — Immortal Dragons, a $40M longevity fund headquartered in Singapore, today announced that its portfolio company Unlimited Bio has registered a Phase 1/2a clinical trial on ClinicalTrials.gov (NCT07443826). The…